Clinical Study on Treatment of Chronic Persistent Bronchial Asthma

  • STATUS
    Recruiting
  • participants needed
    320
  • sponsor
    Shanghai University of Traditional Chinese Medicine
Updated on 29 August 2023

Summary

Investigators aimed to evaluate the clinical efficacy of integrated traditional Chinese and Western medicine in the treatment of asthma, and to further optimize the prescription of Chinese medicine treatment.

Description

The incidence of asthma in China is high and the rate of control is low. Traditional Chinese medicine has a long history of treating asthma, and has a good clinical curative effect.The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to further optimize the prescription of Chinese medicine treatment.
In this study, investigators recruited chronic persistent asthma participants, and gave the corresponding western medicine background treatment and traditional Chinese medicine treatment program for 28 days.Participants will undergo a physical examination, lung function, blood and sputum collection.

Details
Condition Bronchial Asthma
Age 18years - 65years
Treatment Ke Chuan Liu Wei Granule, Yang He Ping Chuan Granule, Ke Chuan Liu Wei Granule placebo, Yang He Ping Chuan Granule placebo
Clinical Study IdentifierNCT03228134
SponsorShanghai University of Traditional Chinese Medicine
Last Modified on29 August 2023

Eligibility

Yes No Not Sure

Inclusion Criteria

Patient diagnosed with chronic persistent asthma
Patients had positive bronchodilator reversibility test or positive bronchial challenge test or more than 50 parts per billion of FENO before
Conform to the predetermined 2 TCM Syndrome Types
Patients who have given written informed consent

Exclusion Criteria

Smoking and continuous exposure to hazardous environment
With fever, or severity of intermittent state, high degree of sustained, or with respiratory failure, etc
Pulmonary emphysema, chronic obstructive pulmonary disease, pulmonary emphysema, pulmonary heart disease, pneumonia, lung cancer and other lung diseases
Patients who are allergic to therapeutic medicine
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.